The DOI matches its Crossref record.
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
Abstract
The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were obtained. For example, limbic periallocortex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: periallocortex (area 28) greater than allocortex (subiculum/CA1 zones of hippocampal formation, area 51) greater than corticoid areas (accessory basal nucleus of amygdala, nucleus basalis of Meynert) greater than proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) greater than nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) greater than primary sensory association cortex (7, 18, 19, 22, 21, 20) greater than agranular cortex (44-5, 8, 6, 4) greater than primary sensory cortex (41-2, 3-1-2, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, parietal, and occipital lobes. In general, NPs were more evenly distributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and occipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and parietal lobe was intermediate. No significant left-right hemispheric differences for NFT or NP densities were found across the population, and there was no relationship between duration of illness and densities of NFTs or NPs. The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, especially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commensurate with their connectional "distance" (i.e., synapses removed) from the limbic areas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The EC is affected severely in Alzheimer disease (AD), likely contributing to memory impairment.”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The EC was chosen because it is highly selectively vulnerable in AD (Hyman et al., 1984(Hyman et al., , 1986;;Arnold et al., 1991;Braak and Braak, 1991;Price et al., 1991;Arriagada et al., 1992a;Fukutani et al., 1995;Solodkin and Van Hoesen, 1996).”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The midfrontal gyrus cortex (corresponding predominantly to Brodmann area 46) was chosen for semi-quantitative image analyses of AD pathology, cellular and synaptic markers because of its important role in complex cognition and its common neuropathological involvement in the spectrum of AD (Arnold, et al., 1991).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arnold, et al., 1991
In the citing paper
“as this region is the first area of the brain involved by the neurofibrillary pathology of AD(4, 5).”
From Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) · cites this paper as [5]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [100]
In the citing paper
“In the early stages of Alzheimer’s disease (AD), the most common form of age-related dementia, clinical symptoms (such as memory loss) are caused by the selective degeneration of principal neurons of the entorhinal cortex layer II (ECII), followed by CA1 pyramidal cells in the hippocampus, and pyramidal neurons in neocortical association areas.”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
In the citing paper
“In contrast, other brain regions, such as the primary sensory cortices, are relatively resistant to degeneration until later stages of the disease (Arnold et al., 1991; Bussière et al., 2003; Fukutani et al., 2000; Gómez-Isla et al., 1996; Hof and Morrison, 1990; Hyman et al., 1984; Morrison and Hof, 1997; West et al., 1994).”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 301–400 of 1,002
Düzel, E., Schütze, H., Yonelinas, A. P., & Heinze, H. (2010) · Hippocampus · doi:10.1002/hipo.20834 · Cited by 124
The primate temporal pole: its putative role in object recognition and memory
Nakamura, K., & Kubota, K. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00227-8 · Cited by 117
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
Ince, P. G., Perry, E. K., & Morris, C. M. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00156.x · Cited by 116
Visuoconstructional problems in dementia: Contribution of executive systems functions.
Freeman, R. Q., Giovannetti, T., Lamar, M., Cloud, B., Stern, R. A., Kaplan, E., & Libon, D. J. (2000) · Neuropsychology · doi:10.1037//0894-4105.14.3.415 · Cited by 114
Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia
Nishioka, N., & Arnold, S. E. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200403000-00008 · Cited by 114
Self-citationFunctional anatomy of human odor sensation, discrimination, and identification in health and aging.
Kareken, D. A., Mosnik, D. M., Doty, R. L., Džemidžić, M., & Hutchins, G. D. (2003) · Neuropsychology · doi:10.1037/0894-4105.17.3.482 · Cited by 120
Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 120
Therapeutic potential of statins in Alzheimer's disease
Kandiah, N., & Feldman, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.352 · Cited by 113
Incomplete achromatopsia in alzheimer's disease
Cronin‐Golomb, A., Sugiura, R., Corkin, S., & Growdon, J. H. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90105-k · Cited by 112
Dong, H., Yuede, C. M., Yoo, H.-S., Martin, M. V., Deal, C., Mace, A. G., & Csernansky, J. G. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.017 · Cited by 112
Retinal neurodegeneration and brain MRI markers: the Rotterdam Study
Mutlu, Ü., Bonnemaijer, P. W. M., Ikram, M. A., Colijn, J. M., Cremers, L. G. M., Buitendijk, G. H. S., Vingerling, J. R., Niessen, W. J., Vernooij, M. W., Klaver, C. C. W., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.003 · Cited by 111
Ding, S., & Hoesen, G. W. V. (2010) · Human Brain Mapping · doi:10.1002/hbm.20940 · Cited by 111
Quantitative MR Imaging in Alzheimer Disease
Ramani, A., Jensen, J. H., & Helpern, J. A. (2006) · Radiology · doi:10.1148/radiol.2411050628 · Cited by 113
Colour vision deficiencies in Alzheimer's disease
Pache, M. (2003) · Age and Ageing · doi:10.1093/ageing/32.4.422 · Cited by 116
Laurent Younes, B., Albert, M., & Miller, M. I. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.04.009 · Cited by 111
Demiral, Ş. B., Tomasi, D., Sarlls, J., Lee, H., Wiers, C. E., Zehra, A., Srivastava, T., Ke, K., Shokri-Kojori, E., Freeman, C. R., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2018.10.043 · Cited by 110
Vascular Risk and β ‐Amyloid Are Synergistically Associated with Cortical Tau
Rabin, J. S., Yang, H., Schultz, A. P., Hanseeuw, B. J., Hedden, T., Viswanathan, A., Gatchel, J. R., Marshall, G. A., Kilpatrick, E. P., Klein, H., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25399 · Cited by 110
Automated MRI measures predict progression to Alzheimer's disease
Desikan, R. S., Cabral, H., Settecase, F., Hess, C. P., Dillon, W. P., Glastonbury, C. M., Weiner, M. W., Schmansky, N. J., Salat, D. H., & Fischl, B. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.023 · Cited by 112
Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska, E., Harrington, C. R., Roth, M., & Wischik, C. M. (1993) · PubMed Central · Cited by 109
Cortical event-related potentials in preclinical familial Alzheimer disease
Golob, E. J., Ringman, J. M., Irimajiri, R., Bright, S., Schaffer, B., Medina, L. D., & Starr, A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1de77 · Cited by 112
Kensinger, E. A., Ullman, M. T., & Corkin, S. (2001) · Hippocampus · doi:10.1002/hipo.1049 · Cited by 107
Ballesteros, S., & Avilés, J. M. R. (2004) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2003.12.008 · Cited by 116
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease
Mielke, R., Schröder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiß, W.-D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050410 · Cited by 107
Cai, H.-Y., Hölscher, C., Yue, X.-H., Zhang, S., Wang, X.-H., Qiao, F., Yang, W., & Qi, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.022 · Cited by 106
Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain
Sepulcre, J., Sabuncu, M. R., Li, Q., Fakhri, G. E., Sperling, R. A., & Johnson, K. A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.011 · Cited by 106
Selden, N. R. W., Geula, C., Hersh, L. B., & Mesulam, M. M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90491-x · Cited by 107
Hof, P. R., Archin, N. M., Osmand, A. P., Dougherty, J. H., Wells, C. E., Bouras, C., & Morrison, J. H. (1993) · Acta Neuropathologica · doi:10.1007/bf00304135 · Cited by 106
The functional anatomy of divided attention in amnestic mild cognitive impairment
Dannhauser, T. M., Walker, Z., Stevens, T., Lee, L., Seal, M., & Shergill, S. S. (2005) · Brain · doi:10.1093/brain/awh413 · Cited by 106
Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI
Hojjati, S. H., Ebrahimzadeh, A., & Abbas Babajani-feremi, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00904 · Cited by 105
Giannakopoulos, P., Hof, P. R., Mottier, S., Michel, J., & Bouras, C. (1994) · Acta Neuropathologica · doi:10.1007/bf00294172 · Cited by 104
Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
Castellani, R. J., & Perry, G. L. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.09.009 · Cited by 104
Alzheimer's disease: Pathogenesis and prevention
Braak, H., & Tredici, K. D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.011 · Cited by 110
The Human Parahippocampal Region: I. Temporal Pole Cytoarchitectonic and MRI Correlation
Blaizot, X., Mansilla, F., Serrano, A. M. I., Constans, J., Salinas-Alaman, A., Pró-Sistiaga, P., Mohedano‐Moriano, A., & Insausti, R. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp289 · Cited by 106
Mechanisms of neuronal death in disease: defining the models and the players
Ribé, E. M., Serrano‐Saiz, E., Akpan, N., & Troy, C. M. (2008) · Biochemical Journal · doi:10.1042/bj20081118 · Cited by 107
Molecular imaging of serotonin degeneration in mild cognitive impairment
Smith, G. S., Barrett, F. S., Joo, J. H., Nassery, N., Savonenko, A. V., Sodums, D. J., Marano, C. M., Munro, C. A., Brandt, J., Kraut, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.007 · Cited by 102
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance
Geula, C., Dunlop, S. R., Ayala, I., Kawles, A. S., Flanagan, M. E., Gefen, T., & Mesulam, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15471 · Cited by 102
Cantone, M., Pino, G. D., Capone, F., Piombo, M., Chiarello, D., Cheeran, B., Pennisi, G., & Lazzaro, V. D. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.04.010 · Cited by 102
Loss of brain inter-frequency hubs in Alzheimer's disease
Guillon, J., Attal, Y., Olivier Colliot, A., Corte, V. L., Dubois, B., Schwartz, D., Chávez, M., & Fallani, F. D. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-07846-w · Cited by 108
Bussière, T., Hof, P. R., Vanbesien-Mailliot, C., Brown, C., Caillet‐Boudin, M., Perl, D. P., Buée, L., & Delacourte, A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050978 · Cited by 102
Hsiao, F., Wang, Y.-J., Yan, S., Chen, W., & Lin, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068792 · Cited by 105
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease
Shin, J., Lee, S., Kim, S., Kim, Y.-B., & Cho, S. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.022 · Cited by 104
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., Machulda, M. M., et al. (2019) · Brain · doi:10.1093/brain/awz025 · Cited by 104
Chapter II Neurobiology and neuropathology of the human hypothalamus
Swaab, D. F. (1997) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(97)80004-8 · Cited by 102
Buldyrev, S. V., Cruz, L., Gómez‐Isla, T., Gómez‐Tortosa, E., Havlin, S., Le, R., Stanley, E., Urbanc, B., & Hyman, B. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060009897 · Cited by 100
Self-citationTosun, D., Schuff, N. W., Truran‐Sacrey, D., Shaw, L. M. J., Trojanowski, J. Q., Aisen, P. S. S., Peterson, R., & Weiner, M. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.030 · Cited by 99
Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta
Cohen, A. D., Rabinovici, G. D., Mathis, C. A., Jagust, W. J., Klunk, W. E., & Ikonomović, M. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00002-7 · Cited by 103
Auhustinack, J. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00042 · Cited by 102
Scarmeas, N., Habeck, C. G., Zarahn, E., Anderson, K. E., Park, A., Hilton, J., Pelton, G. H., Tabert, M. H., Honig, L. S., Moeller, J. R., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.04.032 · Cited by 102
Ringman, J. M., Monsell, S., Ng, D. W., Zhou, Y., Nguyen, A., Coppola, G., Van Berlo, V., Mendez, M. F., Tung, S., Weintraub, S., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv028 · Cited by 99
Lai, J., Hu, M., Wang, H., Hu, M. Y., Long, Y., Miao, M., Li, J.-C., Wang, X., Kong, L., & Hong, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.011 · Cited by 99
Enhanced Stimulus Strength Improves Visual Cognition in Aging and Alzheimer's Disease
Cronin‐Golomb, A., Gilmore, G. C., Neargarder, S. A., Morrison, S. R., & Laudate, T. M. (2007) · Cortex · doi:10.1016/s0010-9452(08)70693-2 · Cited by 98
Tau‐66: evidence for a novel tau conformation in Alzheimer's disease
Ghoshal, N., García‐Sierra, F., Fu, Y., Beckett, L. A., Mufson, E. J., Kuret, J., Berry, R. W., & Binder, L. I. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00346.x · Cited by 97
Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment
Moretti, D. V., Miniussi, C., Frisoni, G. B., Geroldi, C., Zanetti, O. O., Binetti, G. G., & Rossini, P. M. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.09.059 · Cited by 97
Predicting the location of entorhinal cortex from MRI
Fischl, B. R., Stevens, A. A., Rajendran, N., Yeo, B. T. T., Greve, D. N., Leemput, K. V., Polimeni, J. R., Kakunoori, S., Buckner, R. L., Pacheco, J. L., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.033 · Cited by 102
Self-citationCholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
Perez, S. E., Dar, S., Ikonomović, M. D., DeKosky, S. T., & Mufson, E. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.015 · Cited by 100
Prevalence and incidence of major depression in Alzheimer's disease
Weiner, M., Edland, S. D., & Luszczynska, H. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1006 · Cited by 99
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography
Klunk, W. E., Engler, H., Nordberg, A., Bacskai, B. J., Wang, Y., Price, J. C., Bergström, M., Hyman, B. T., Långström, B., & Mathis, C. A. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00092-3 · Cited by 96
Self-citationSheffield, L. G., Marquis, J. G., & Berman, N. E. J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01037-5 · Cited by 96
Pietrini, P., Furey, M. L., Graff‐Radford, N. R., Freo, U., Alexander, G. E., Grady, C. L., Dani, A., Mentis, M. J., & Schapiro, M. B. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.10.1261 · Cited by 96
Structural Magnetic Resonance Imaging in Established and Prodromal Alzheimer Disease: A Review
Atiya, M., Hyman, B. T., Albert, M., & Killiany, R. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00010 · Cited by 101
Self-citationDHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effects
Perez, S. E., Berg, B. M., Moore, K. A., He, B., Counts, S., Fritz, J. J., Hu, Y., Lazarov, O., Lah, J. J., & Mufson, E. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22266 · Cited by 99
Seladin-1 transcription is linked to neuronal degeneration in Alzheimer’s disease
Iivonen, S., Hiltunen, M., Alafuzoff, I. I., Mannermaa, A., Kerokoski, P., Puoliväli, J. T., Salminen, A., Helisalmi, S., & Soininen, H. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00180-x · Cited by 97
Vision function abnormalities in Alzheimer disease
Tzekov, R., & Mullan, M. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.10.002 · Cited by 94
Resting-State Oscillatory Brain Dynamics in Alzheimer Disease
de Haan, W., Stam, C. J., Jones, B. F., Zuiderwijk, I. M., van Dijk, B. W., & Scheltens, P. (2008) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31817da184 · Cited by 94
Temporal Sequence of Alzheimer’s Disease-Related Pathology
Braak, H., & Braak, E. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_14 · Cited by 95
Activity changes and marked stereotypic behavior precede Aβ pathology in TgCRND8 Alzheimer mice
Ambrée, O., Touma, C., Görtz, N., Keyvani, K., Paulus, W., Palme, R., & Sachser, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.009 · Cited by 93
Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability
Wang, X., Michaelis, M. L., & Michaelis, E. K. (2010) · Current Genomics · doi:10.2174/138920210793360943 · Cited by 94
Neuropathologic Changes of the Temporal Pole in Alzheimer's Disease and Pick's Disease
Arnold, S. E., Hyman, B. T., & Hoesen, G. W. V. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540140051014 · Cited by 93
Self-citationReduced temporal lobe blood flow in alzheimer's disease
Eberling, J. L., Jagust, W., Reed, B., & Baker, M. G. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90076-a · Cited by 93
Irizarry, M. C., Cheung, B. S., Rebeck, G. W., Paul, S. M., Bales, K. R., & Hyman, B. T. (2000) · Acta Neuropathologica · doi:10.1007/s004010000263 · Cited by 93
Self-citationNmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity
Yan, T., Feng, Y., Zheng, J., Ge, X., Zhang, Y., Wu, D., Zhao, J., & Zhai, Q. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2009.09.007 · Cited by 92
Csernansky, J. G., Wang, L., Joshi, S. C., Ratnanather, J. T., & Miller, M. I. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.025 · Cited by 92
Contingent Vulnerability of Entorhinal Parvalbumin-Containing Neurons in Alzheimer’s Disease
Solodkin, A., Veldhuizen, S. D., & Hoesen, G. W. V. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03311.1996 · Cited by 92
Predicting the location of human perirhinal cortex, Brodmann's area 35, from MRI
Augustinack, J. C., Huber, K. E., Stevens, A. A., Roy, M., Frosch, M. P., van der Kouwe, A. J. W., Wald, L. L., Leemput, K. V., McKee, A. C., & Fischl, B. R. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.071 · Cited by 100
Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease
Wolk, D. A., Das, S. R., Mueller, S. G., Weiner, M. W., & Yushkevich, P. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.011 · Cited by 92
Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe
Yushkevich, P. A., Muñoz, M., Martin, M. M. I. D. O., Ittyerah, R., Lim, S., Ravikumar, S., Bedard, M. L., Pickup, S., Liu, W., Wang, J., et al. (2021) · Brain · doi:10.1093/brain/awab262 · Cited by 96
The autonomic-related cortex: pathology in Alzheimer's disease
Chu, C. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.1.86 · Cited by 91
PET and SPECT Imaging in Psychiatric Disorders
Zipursky, R. B., Meyer, J. H., & Verhoeff, N. P. L. G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200303 · Cited by 91
Alterations of visual search strategy in Alzheimer's disease and aging.
Rösler, A., Mapstone, M. E., Hays, A. K., Mesulam, M. M., Rademaker, A., Gitelman, D. R., & Weıntraub, S. (2000) · Neuropsychology · doi:10.1037//0894-4105.14.3.398 · Cited by 95
Cerebrospinal Fluid Aβ42, Phosphorylated Tau181, and Resting-State Functional Connectivity
Wang, L. Y., Brier, M. R., Snyder, A. Z., Thomas, J., Fagan, A. M., Xiong, C., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., & Ances, B. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3253 · Cited by 90
The morbid anatomy of dementia in Parkinson’s disease
Kalaitzakis, M. E., & Pearce, R. K. B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0597-x · Cited by 90
Divergent phosphorylation pattern of tau in P301L tau transgenic mice
Deters, N. A., Ittner, L. M., & Götz, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06318.x · Cited by 91
The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease
Miller, M. I., Younes, L., Ratnanather, J. T., Brown, T., Trinh, H., Postell, E., Lee, D. S., Wang, M.-C., Mori, S., O'Brien, R., et al. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.09.001 · Cited by 88
Synaptic dysfunction in early phases of Alzheimer's Disease
Pelucchi, S., Gardoni, F., Luca, M. D., & Marcello, E. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 95
The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's DiseasePreprint
Walker, L. C., Schelle, J., & Jucker, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024398 · Cited by 95
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Gómez, W., Morales, R., Maracaja‐Coutinho, V., Parra, V., & Nassif, M. (2020) · Aging · doi:10.18632/aging.102677 · Cited by 94
Molecular imaging in dementia: Past, present, and future
Laforce, R. J., Soucy, J., Sellami, L., Dallaire‐Théroux, C., Brunet, F., Bergeron, D., Miller, B. L., & Ossenkoppele, R. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2855 · Cited by 88
Differential effects of aging and Alzheimer's disease on conceptual implicit and explicit memory.
Monti, L. A., Gabrieli, J. D. E., Reminger, S. L., Rinaldi, J., Wilson, R. S., & Fleischman, D. A. (1996) · Neuropsychology · doi:10.1037/0894-4105.10.1.101 · Cited by 87
Human fetal hippocampal development: II. The neuronal cytoskeleton
Arnold, S. E., & Trojanowski, J. Q. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960401)367:2 · Cited by 87
Self-citationMirror trends of plasticity and stability indicators in primate prefrontal cortex
García‐Cabezas, M. Á., Joyce, M. K. P., John, Y. J., Zikopoulos, B., & Barbas, H. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13706 · Cited by 88
Alzheimer?s disease: intraneuronal alterations precede insoluble amyloid-$beta; formation
Braak, H., & Tredici, K. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.015 · Cited by 93
Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review
Kepe, V., Moghbel, M. C., Långström, B., Zaidi, H., Vinters, H. V., Huang, S., Satyamurthy, N., Doudet, D. J., Mishani, E., Cohen, R. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130485 · Cited by 87
Pennisi, G., Ferri, R., Lanza, G., Cantone, M., Pennisi, M., Puglisi, V., Malaguarnera, G., & Bella, R. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0554-9 · Cited by 85
Pereira, M. L. G. D. F., Camargo, M. V. Z. D. A., Aprahamian, I., & Forlenza, O. V. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s55371 · Cited by 90
Hof, P. R., Bussière, T., Gold, G., Kövari, E., Giannakopoulos, P., Bouras, C., Perl, D. P., & Morrison, J. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.55 · Cited by 85
Use of structural imaging to study the progression of Alzheimer's disease
Smith, A. D., & Jobst, K. A. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011568 · Cited by 85
Vermersh, P., Wattez, A., Delacourte, A., Robitaille, Y., Bernier, L., & Gauvreau, D. (1994) · Acta Neuropathologica · doi:10.1007/bf00293317 · Cited by 85
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice
Perez, S. E., Lazarov, O., Koprich, J. B., Chen, E., Rodriguez‐Menendez, V., Lipton, J. W., Sisodia, S. S., & Mufson, E. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2773-05.2005 · Cited by 86
Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease
Menschik, E. D., & Finkel, L. H. (1998) · Artificial Intelligence in Medicine · doi:10.1016/s0933-3657(98)00006-2 · Cited by 85
Metadata
- Authors
- Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W.
- Affiliations
- University of Iowa (US)
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 103-116
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2029923284
- Cited by
- 1,380
- References
- 0
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 32 · 2023: 34 · 2022: 31 · 2021: 45 · 2020: 36 · 2019: 41 · 2018: 47 · 2017: 43 · 2016: 42 · 2015: 40 · 2014: 42 · 2013: 54 · 2012: 42
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (P019632)
- National Institute on Aging (AG-08487)
- National Institute of Neurological Disorders and Stroke (R01NS014944, NS-14944)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, neuritic plaques, cortical topography, neuroanatomy, allocortex, temporal lobe, occipital lobe, frontal lobe, parietal lobe, laminar distribution, thioflavin S, thionin, amygdala, nucleus basalis of Meynert
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cerebral Cortex, Female, Histocytochemistry, Humans, Male, Middle Aged, Neurites, Tissue Embedding, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
